TabletsPrednisoneTablets, Enteric-CoatedVincristineChemistry, PharmaceuticalExcipientsCyclophosphamideDrug CompoundingGlucocorticoidsDelayed-Action PreparationsTechnology, PharmaceuticalDoxorubicinMethylcelluloseProcarbazineAdministration, OralAntineoplastic Combined Chemotherapy ProtocolsPrednisoloneMechlorethaminePowdersAzathioprineImmunosuppressive AgentsTreatment OutcomeDrug Therapy, CombinationDrug Administration ScheduleSolubilityMelphalanMitoxantroneHardnessAntibodies, Monoclonal, Murine-DerivedAnti-Inflammatory AgentsBleomycinMethotrexateColor TherapyLubricantsRemission InductionDosage FormsChlorambucilTherapeutic EquivalencyCapsulesLymphoma, Non-HodgkinBiological AvailabilityCyclosporineCelluloseDouble-Blind MethodPovidoneHodgkin DiseaseLymphoma, Large B-Cell, DiffuseDrug StabilityMycophenolic AcidTime FactorsFollow-Up StudiesHardness TestsAdministration, BuccalVinblastineAsparaginaseAdrenal Cortex HormonesThalidomideMultiple MyelomaKidney TransplantationCross-Over StudiesRecurrenceEtoposideClinical Trials as TopicSurvival AnalysisGraft RejectionDisease-Free SurvivalTacrolimusCompressive StrengthCarboxymethylcellulose SodiumMethylprednisoloneSurvival RateSuspensionsProspective StudiesCombined Modality TherapyNephrotic SyndromeDose-Response Relationship, DrugPolymethacrylic AcidsPowder DiffractionPharmaceutic AidsAdministration, SublingualPolymyalgia Rheumatica6-MercaptopurineCyclosporinsEtiocholanoloneLymphoma, FollicularVindesineDrug CombinationsCarmustineRetrospective StudiesAndrostenolsTaxoidsPrognosisAcetaminophenCapillary FragilityPorosityDrug StorageHealthy VolunteersImmunosuppressionDrug PackagingLomustine